Company
Established in 2022, our company is a startup in the scientific computing service industry, specialising in providing solutions in the field of molecular simulation and AI. Our team consists of experienced, creative, and passionate professionals.
Our has a well-defined organisational structure comprising three core departments. The Research and Development department is dedicated to innovating and developing cutting-edge products and technologies to meet the evolving needs of our customers. This includes the development of state-of-the-art scientific computing programs and the establishment of high-performance servers. The Sales and Marketing department focuses on building strong customer relationships and effectively promoting and selling our products and services. Lastly, the Operations department ensures the smooth day-to-day operations and efficient project management of our business.
Description
Hong Kong Putai Medical Technology Company Limited is a startup specialising in scientific computing solutions startup. We excel in utilising cutting-edge simulation techniques to model and analyse complex molecular systems, providing valuable insights into chemical, biological, and medical processes for our clients, and driving scientific discovery and innovation.
Technology
Our company provides solutions in computational simulation of drug molecule pharmacology. By simulating the interactions between molecules and targets, we can predict the binding modes, affinity, and inhibitory activity of drug molecules. This aids in expediting the drug development process, optimising candidate drug structures, and forecasting their pharmacological effects within the human body.
AI-based drug screening and design:
We have developed AI-powered tools for drug screening and design. Through the analysis of vast amounts of compound data and pharmacological information, we leverage machine learning and data mining techniques to establish prediction models and algorithms for swift screening of potential drug candidates and the design of novel drug molecules. This AI-based approach accelerates the drug discovery process and enhances research and development efficiency.
Prediction of drug molecule crystal forms:
Our team is also dedicated to predicting the crystal forms of drug molecules. Through computational simulations and crystallographic analysis, we can predict the crystalline forms and crystal structures of drug molecules in the solid state. This is crucial for drug stability, bioavailability, and the development of drug formulations. Our crystal form prediction technology assist researchers in optimising the physical properties of drugs and guides the design of drug formulations and manufacturing processes.
